We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Sanofi Targets Accord Over Generic Taxotere

Law360 (January 7, 2011, 3:43 PM EST) -- Sanofi-Aventis US LLC has launched a suit seeking to stop Accord Healthcare Inc. USA from taking steps to market a generic copycat of cancer treatment Taxotere.

New Jersey-based Sanofi and Paris-based Aventis Pharma SA lodged a suit in the U.S. District Court for the District of Delaware on Thursday in response to Accord’s attempt to secure federal approval for a generic form of docetaxel, the active ingredient in Taxotere, before the expiration of two patents — the same patents that were invalidated in a related case...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.